Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
Bommer
J
J
Medical Clinic, University of Heidelberg, FRG.
Kugel
M
M
Schoeppe
W
W
Brunkhorst
R
R
Samtleben
W
W
Bramsiepe
P
P
Scigalla
P
P
D000328:Adult; D000740:Anemia / Q000209:etiology / Q000628:therapy*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004920:Erythropoiesis; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D006400:Hematocrit; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D011897:Random Allocation; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use*
D011994:Recombinant Proteins; D004921:Erythropoietin